|
- 积分
- 80
- 威望
- 80
- 包包
- 167
|
回复 蒲公英 的帖子
# g3 h5 i: y' ?! `1 m- w9 N/ o4 q
0 \. V5 _. J; |# m& i3 b9 Q参考文献：0 y5 U/ V, {+ n' \
1 Krampera M, Glennie S, Dyaon J，et al. Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigenspecific T cells to their cognate peptide. Blood, 2003;101:3722-3729
" M6 L4 y) r; ^5 Q; \( ^/ |- U2 Potian JA, Aviv H, Ponzio NM, et al. Vetolike activity of mesenchymal stem cells: functional discrimination between cellular responses to alloantigens and recall antigens. J Immunol, 2003;171:3426-34341 m- b( d! h$ {( x* \6 }, H
3 Klyushnenkova E, Mosca JD, Zernetkina V, et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. J Biomed Sci, 2005;12:47-57' P3 e8 u/ ^" Q8 U
# T% C/ k5 ^( f# T4 DiNicola M, CarloStella C, Magni M, et al. Human bone marrow stromal cells suppress Tlymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood, 2002;99:3838-3843# n2 L [; U5 Z
8 q& I6 e" i3 a% v+ l$ k2 W6 B
5 Rasmusson I, Ringden O, Sundberg B, et al. Mesenchymal stem cells inhibit lymphocyte proliferation by mitrogens and alloantigens by different mechanisms. Exp Cell Res, 2005; 305：33-41
, R! D3 P, L% B G; ]1 u+ o+ J6 x, Z5 C* ~
6 Sun S，Guo Z，Xiao X，et al. Isolation of mouse marrow mesenchymal progenitors by a novel and reliable method. Stem Cell, 2003;21:527-535- o6 L, `) I l8 R' M9 X9 D6 c, D
: \" c, X* Z! L8 X7 Maccario R, Podesta M, Moretta A, et al. Interaction of human mesenchymal stem cells with cells involved in alloantigenspecific immune response favors the differentiation of CD4 Tcell subsets expressing a regulatory/suppressive phenotype. Haematologica, 2005;90:516-525
. \: d4 j- k8 Y& O1 q. }4 M% _4 Z8 i8 D6 u- j4 g" C( w% }
8 Djouad F, Plence P, Bony C, et al. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood, 2003;102: 3837-3844
7 d4 {' }' ]9 m
! N/ t: N3 w/ A" _/ ^9 Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell response. Blood, 2005; 105:1815-1822
7 {) L$ s/ r0 n0 T& x
* {5 i8 }3 F9 y- H, X! @/ Y10 Beyth S, Borovsk Z, Mevorach D，et al. Human mesenchymal stem cells alter antigen presenting cell maturation and induce Tcell unresponsiveness. Blood, 2005; 105:2214-2219
! ~ \5 [4 X/ |( c4 p
9 m) h1 i- k0 ]+ Y: i7 J; h11 Jiang XX, Zhang Y, Liu B, et al. Human mesenchymal stem cells inhibit differentiation and function of monocytederived dentritic cells. Blood, 2005; 105; 4120-4126' q. _4 N1 X4 G8 g' l$ A
1 s/ [1 P' b4 `8 E: q
12 Nauta AJ, Kruisselbrink AB, Lurvink E, et al. Mesenchymal stem cells inhibit generation and function of both CD34 derived and monocytederived dendritic cells. J Immunol, 2006; 177: 2080-20873 g0 n6 R4 b1 ^* `* w1 K6 P
3 e8 N) K" d% V: l* U' S
13 Rasmusson I, Ringden O, Sundberg B, et al. Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells. Transplantation, 2003; 76 :1208-1213
3 J5 B! t6 C. G& R- W/ b: p5 W. g' y2 x/ L2 M
14 Angoulvant D, Clerc A, Benchalal S, et al. Human mesenchymal stem cells suppress induction of cytotoxic response to alloantigens. Biorheology, 2004; 41:469-476, n2 S* j$ W6 p
7 E) i! l/ r/ B: K% I6 ?
15 Bartholomew A, Sturgeon C, Siatskas M, et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp Hematol, 2002; 30: 42-48
0 b# e; T+ x: R# Q0 x8 J7 L4 ?) _! v2 b7 z5 { P* w0 Y
16 Guo Z, Li H, Li X, et al. In vitro characteristics and in vivo immunosuppressive activity of compact bonederived murine mesenchymal progenitor cells. Stem Cells,2006; 24: 992-1000" `3 o8 Q/ [% w# o' ^! h
2 [" Z: y- ?/ _ Q( {17 Zappia E, Casazza S, Pedemonte E, et al. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T cell anergy. Blood, 2005; 106: 1755-1761
. i5 i' ] X- ], @0 _: m* E3 j
6 _2 D7 y& b" T5 j2 v1 p. s. N18 Lazarus HM, Haynesworth SE, Gerson SL, et al. Ex vivo expansion and subsequent infusion of human bone marrowderived stromal progenitor cells (mesenchymal stem cells): implication for therapeutic use. Bone Marrow Transplant, 1995; 16: 557-564$ q. [* q! _. q* ]6 ^
% O6 E5 @0 Z/ b1 R( U/ g# z+ t
19 Lazarus HM, Koc ON, Devine SM, et al. Cotransplantation of HLAidentical sibling cultureexpanded mesenchymal stem cells and hematopioetic stem cells in hematologic malignancy patients. Biol Blood Marrow Transplant, 2005; 11:389-398* `9 }- |# z9 Q9 K2 z! S# |4 v% C
) U5 z1 C c3 I4 c
20 Lee ST, Jang JH, Cheong JW, et al. Treatment of highrisk acute myelogenous leukemia by myeloablative chemoradiotherapy followed by coinfusion of T celldepleted haematopioetic stem cells and cultureexpanded marrow mesenchymal stem cells from a related donor with one fully mismatched human leucocyte antigen haplotype. Br J Haematol, 2002; 118:1128-1131
) a$ H. ]3 d3 u. \& N2 s2 f# t3 f6 Q
21 LeBlanc K, Rasmusson I, Sundberg B, et al. Treatment of severe acute graftversushost disease with third party haploidentical mesenchymal stem cells. Lancet, 2004; 363(9419):1439-14110 ~( I) A" B, a9 U. w; O
|
-
总评分: 威望 + 2
包包 + 10
查看全部评分
|
发表于 2013-3-25 12:36
大家帮忙看看，给点意见和建议哈~
我也只是列举了一小部分
发表于 2013-3-31 09:05
